Step 1 of 4 25% Learner Objectives After participating in this activity, learners should be able to: Episode Specific: Outline the benefits of prescribing buprenorphine for medication treatment of opioid use disorder. Describe new challenges with opioid use disorder due to fentanyl and apply strategies related to treatment. Find and apply resources and guidelines to start prescribing buprenorphine for treatment of OUD due to fentanyl. Podcast Series: Understand and apply to practice new legislation updates related to better prescribing Adopt approaches in safe prescribing for buprenorphine, sedatives, chronic opioid prescribing, co-prescribing, variants/novel drugs, and new trends Put into practice treatment of opioid use disorder and overcome barriers Apply strategies to engage and better serve communities with treatment of opioid use disorder Taking into account how well the learner objectives were met, how would you rate the podcast episode?1=Poor23=Good45=ExcellentList one or two strategies that you will put in pratice. An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests. Did you perceive any bias toward a “commercial interest” in any presentation? Yes No If Yes, please explainWhat barriers do you face in implementing what you learned at the activity?Do you want to claim CME credit?(Required) Yes No CME Credit Claim FormTo claim CME credit, please provide your contact information below.First Name(Required)Last Name(Required)Credentials(Required)AddressCity/TownStateZipCountryEmail Address(Required)Company CME Accreditation The WSMA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The WSMA designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit Claim Physicians: The number of credits claimed equals the number of AMA PRA Category 1 CreditsTM awarded, with one hour of participation equaling one AMA PRA Category 1 CreditTM. Physicians should claim credit in 15 minute (i.e. 0.25 credit) increments. All other attendees: Please complete this form so that we may verify your participation in this activity, which was designated for 1 AMA PRA Category 1 CreditsTM awarded, with one hour of participation equaling one AMA PRA Category 1 CreditsTM. Attestation & Credits Claimed(Required) I attest that I have viewed/listened to the BPBT Podcast #18: Buprenorphine Prescribing and Fentanyl (0.75 hours)Number of CME credits claimed (up to 0.75)(Required)Please enter a number from 0 to 0.75. Are you claiming MOC credit? By claiming MOC credit, you are granting the WSMA to share your learner data with the ACCME and the certifying Board(s).(Required) Yes No Quiz To claim MOC credit, you must receive a 100% score on the quiz. Participants may take the quiz multiple times. Which of the following is NOT a benefit of buprenorphine for treatment of opioid use disorder (OUD)?(Required) Buprenorphine and methadone may reduce mortality by 50%. Buprenorphine shows a ceiling effect of opioid induced effects, this helps with reducing cravings and withdrawal while lowering risk of overdose. Generally, buprenorphine is safer compared to methadone, especially when combined with sedation medication or other substances. Buprenorphine is highly regulated and patients are required to be monitored. Selection is incorrect. Try again. You must select the correct answer to move forward.Correct! In the episode, Callan Fockele, MD, explained how buprenorphine is an effective medication to reduce withdrawal and cravings associated with OUD and may reduce mortality from OUD by 50%. Nathan Schlicher, MD, described that historically, prescribers may recall that prescribing methadone and buprenorphine were both highly regulated, and prescribers may incorrectly associate buprenorphine with the same dangers as methadone. Prescribers may need to build awareness that buprenorphine is generally safer and associated with fewer side effects compared to methadone. The x-waiver or special certification to prescribe buprenorphine was removed in 2023. What changes are occurring in the treatment and management of opioid use disorder due to fentanyl?(Required) Fentanyl is more common compared to heroin. Fentanyl is short-acting and more potent than heroin. The pill packs of fentanyl may contain unknown substances to the user. Patients may experience precipitated withdrawal symptoms after starting buprenorphine due to the nature of fentanyl, which sometimes stays in fatty tissues or muscles for a longer time. All the above. Selection is incorrect. Try again. You must select the correct answer to move forward.Correct! Dr. Fockele and Dr. Schlicher agreed that currently, fentanyl is much more common compared to heroin. Note that Dr. Fockele explained fentanyl is 50x more potent than heroin. Dr. Fockele also described fentanyl as a fast-acting opioid that leaves the blood stream quickly, however, fentanyl will linger in fatty tissues and muscles. This may result in precipitated withdrawal symptoms even after the patient has started buprenorphine. Dr. Fockele expressed that the precipitated withdrawal is a terrible experience especially for a patient who wants to get started on new medication. Dr. Schlicher noted that rumors about this experience could spread and suggested that prescribers may want to inform patients about the potential risk of precipitated withdrawal. Dr. Fockele recommended having a conversation on how to manage precipitated withdrawal if it arises. Review the presentation slides to learn more and resources are available here from ScalaNW.Is the following statement true or false? Prescribing buprenorphine for opioid use disorder due to fentanyl requires a specialty in addiction medicine.(Required) True False Selection is incorrect. Try again. You must select the correct answer to move forward.Correct! In the podcast episode, Dr. Callan Fockele explained that she completed a fellowship in addiction medicine and concludes that prescribers don't necessarily need a specialization in addiction medicine. With the recent removal of the x-waiver, prescribing buprenorphine for OUD or overdose has become easier. Dr. Fockele also shared evidence-based protocols and patient-centered care strategies, such as offering a piece of hard candy after the buprenorphine film is dissolved to improve the taste. Be sure to revisit the episode to learn more or ask about protocols at your organization. You have passed your quiz! MOC Credit Claim FormYou passed the required quiz with 100% score! To claim MOC credit, please provide your date of birth, certification board, and board learner ID.You will need to enter your certification board and learner ID below. Please use the link below to look up your learner ID for your respective board. American Board of Internal Medicine (ABIM) https://www.abim.org/verify-physician.aspx American Board of Anesthesiology (ABA) https://theaba.org/diplomate%20directory.html American Board of Otolaryngology (ABOHNS) https://www.abohns.org/verify-certification American Board of Pathology (ABPath) American Board of Pediatrics (ABP) https://www.abp.org/verification-certification American Board of Surgery (ABS) American Board of Thoracic Surgery (ABTS)Certification Board(Required)Select a certification board from the menuAmerican Board of Internal Medicine (ABIM)American Board of Anesthesiology (ABA)American Board of Otolaryngology – Head and Neck Surgery (ABOHNS)American Board of Pathology (ABPath)American Board of Pediatrics (ABP)American Board of Surgery (ABS)American Board of Thoracic Surgery (ABTS)Board Not Listed (You may try self-claming)Certification Board Learner ID(Required)Do you need to add another board? Yes No Certification Board #2(Required)Select a certification board from the menuAmerican Board of Internal Medicine (ABIM)American Board of Anesthesiology (ABA)American Board of Otolaryngology – Head and Neck Surgery (ABOHNS)American Board of Pathology (ABPath)American Board of Pediatrics (ABP)American Board of Surgery (ABS)American Board of Thoracic Surgery (ABTS)Board Not Listed (You may try self-claming)Certification Board Learner ID #2(Required)Date of Birth (mm/dd only, do not include year)(Required)Attestation(Required) I attest that I met the minimum threshold for participation for this activity by listening to or viewing the entire recording and passing the online quiz. By submitting this attestation, you are giving WSMA the permission to share your learner data with the ACCME and the certifying Board(s). Enter the amount of MOC Credit (up to 0.75)(Required)Please enter a number from 0 to 0.75.
